Showing results (101-110 of 353) with videos related to

Sort By:
Pageof 36
Cancer Medicine|May 27, 2020
Plasma protein expression differs between colorectal cancer patients depending on primary tumor locationMatilda Holm, Sakari Joenväärä, Mayank Saraswat, et al.
International Journal of Molecular Sciences|March 25, 2022
Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal AdenocarcinomaMirjami Kaasinen, Jaana Hagström, Harri Mustonen, et al.
JOP : Journal of the Pancreas|July 8, 2009
Syndecan-1 and tenascin expression in cystic tumors of the pancreasLeena Kylänpää, Jaana Hagström, Anna Lepistö, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 5, 2005
Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patientsPäivi Siironen, Johanna Louhimo, Stig Nordling, et al.
Journal of Clinical Pathology|August 3, 2013
Adrenocortical tumours: high CT attenuation value correlates with eosinophilia but does not discriminate lipid-poor adenomas from malignancyMirkka Pennanen, Merja Raade, Johanna Louhimo, et al.
Pathology, Research and Practice|December 5, 2020
Matrix metalloproteinase-7, -8, -9, -15, and -25 in minor salivary gland adenoid cystic carcinomaHanna Hämetoja, Antti Mäkitie, Leif Bäck, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 28, 2019
The expression and prognostic value of stem cell markers Bmi-1, HESC5:3, and HES77 in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinomaHesham Mohamed, Jaana Hagström, Lauri Jouhi, et al.
Pancreas|June 24, 2024
The Prognostic Significance of Collagen VI in Pancreatic Ductal AdenocarcinomaElla Kesti, Emmy Borgmästars, Jaana Hagström, et al.
BMC Cancer|July 10, 2014
A comparative study of two PODXL antibodies in 840 colorectal cancer patientsTuomas Kaprio, Jaana Hagström, Christian Fermér, et al.
Pageof 36